Valuation: Star Scientific, Inc.

Market Cap 153K 133K 124K 114K 215K 14.63M 218K 1.46M 573K 7.29M 576K 563K 24.15M P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 20.01M 17.36M 16.16M 14.84M 28.05M 1.91B 28.5M 190M 74.78M 951M 75.15M 73.5M 3.15B EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.53%-3.12%+51.15%+150.58% 1,030B
+0.21%-1.13%+53.26%+46.92% 617B
-2.51%-2.33%+32.56%+66.35% 455B
+0.06%+1.17%+36.21%+31.25% 350B
-0.14%-0.83%+33.24%+40.28% 299B
-0.69%-0.44%+9.86%+14.23% 265B
-7.37%-4.31%-5.69%-41.99% 225B
-0.64%+3.68%+27.80%+62.95% 209B
-0.82%-0.50%+13.46%+69.41% 163B
Average -0.83%+4.83%+27.98%+48.89% 401.41B
Weighted average by Cap. -0.24%+4.87%+36.61%+70.85%

Financials

2014 2015
Net sales - -
Net income -38.52M -33.41M -31.1M -28.57M -53.99M -3.67B -54.86M -366M -144M -1.83B -145M -141M -6.06B -6.84M -5.94M -5.53M -5.08M -9.59M -653M -9.75M -65.09M -25.58M -325M -25.71M -25.14M -1.08B
Net Debt -45K -39.04K -36.33K -33.38K -63.08K -4.29M -64.09K -428K -168K -2.14M -169K -165K -7.08M 19.86M 17.23M 16.03M 14.73M 27.83M 1.89B 28.28M 189M 74.21M 943M 74.57M 72.93M 3.13B
Logo Star Scientific, Inc.
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-